BB
BRTbio provides high-quality, diverse macrocycle libraries using a proprietary platform to accelerate early-stage drug discovery. This technology enables rapid identification of promising drug leads targeting challenging, hard-to-drug targets. The resulting macrocycles offer superior affinity, selectivity, and drug-like properties for therapeutic development in areas like oncology and infectious diseases.
Updated 3 months ago
Funding
$770K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- BRTbio provides high-quality, diverse macrocycle libraries using a proprietary platform to accelerate early-stage drug discovery. This technology enables rapid identification of promising drug leads targeting challenging, hard-to-drug targets. The resulting macrocycles offer superior affinity, selectivity, and drug-like properties for therapeutic development in areas like oncology and infectious diseases.